POSSIBILITIES OF USING DENOSUMAB IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
About the Authors
I. V. KryukovaRussian Federation
Moscow
A. V. Dreval
Russian Federation
Moscow
L. H. Tevosyan
Russian Federation
Moscow
E. Yu. Polyakova
Russian Federation
Moscow
I. A. Barsukov
Russian Federation
Moscow
O. N. Zolotareva
Russian Federation
Moscow
Review
For citations:
Kryukova I.V., Dreval A.V., Tevosyan L.H., Polyakova E.Yu., Barsukov I.A., Zolotareva O.N. POSSIBILITIES OF USING DENOSUMAB IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Osteoporosis and Bone Diseases. 2020;23(2):80-81. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).